The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The company announced positive results in an early-stage trial of the individualized cancer vaccine it developed with Merck.
The filings signal the growing use cases for AI in healthcare settings, but also the risks that may accompany using AI in clinical care.
David Calhoun enjoyed a 45% jump from 2022, but the aerospace giant has started to tie executive pay to broader safety goals.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
A GLP-1 medication from French drugmaker Sanofi — similar to Ozempic — was found to slow Parkinson’s in a small mid-stage trial.
Alaska Airlines has received $160 million from Boeing in compensation after a door plug blew off one of its planes.
Starting this summer, DoorDash will contribute to savings accounts for its delivery couriers in Pennsylvania.
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
Bob Iger is emerging victorious in Disney’s epic board seat battle with infamous activist investor Nelson Peltz.
Elon Musk’s Tesla wrangled the crown of the world’s top EV seller away from China’s BYD this quarter, but it’s not taking any victory laps.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.